Drugmakers Prepare Response as Regulator Targets Brand Name Extensions

Pharmaceuticals

15 July 2026 at 9:15 am

Drugmakers Prepare Response as Regulator Targets Brand Name Extensions

News Studio

Summary

Drugmakers are preparing their response as the DCGI targets the practice of extending primary brand names to treat unrelated illnesses. The regulator has warned pharmaceutical associations of strict action against this practice.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from AI News Studio.

News Studio iconFAQ

Newsroom FAQs

About the public News Studio news feed powered by NewsEngine.

Drugmakers Prepare Response as Regulator Targets Brand Name Extensions | News Studio | News Studio